Cas:184101-38-0 1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene manufacturer & supplier

Chemical Name:1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene

CAS.NO:184101-38-0

Synonyms:1,4-Bis(4-(4-diphenylamino)-phenyl-1,3,4-oxidiazol-2-yl)-benzene

Molecular Formula:C₄₆H₃₆N₆O₂

Molecular Weight:704.81700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:56.14000

Exact Mass:704.29000

LogP:9.93920

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4-Bis(4-(4-diphenylamino)-phenyl-1,3,4-oxidiazol-2-yl)-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Bis(4-(4-diphenylamino)-phenyl-1,3,4-oxidiazol-2-yl)-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Bis(4-(4-diphenylamino)-phenyl-1,3,4-oxidiazol-2-yl)-benzene Use and application,1,4-Bis(4-(4-diphenylamino)-phenyl-1,3,4-oxidiazol-2-yl)-benzene technical grade,usp/ep/jp grade.

Related News: Covington has handled dozens of cases for Lilly over the past 20 years, according to the Westlaw database of legal cases and press releases, including intellectual property matters, personal injury lawsuits and class actions. 1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene supplier At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene vendor Covington has handled dozens of cases for Lilly over the past 20 years, according to the Westlaw database of legal cases and press releases, including intellectual property matters, personal injury lawsuits and class actions. 1,4-bis(5-(4-diphenylamino)phenyl-1,3,4-oxadiazol-2-yl)benzene factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.